ArticleDiabetes technology & therapeutics2022
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections.
Open access · greenAbstract read
In one paragraph
Article in Diabetes technology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 20 citations in OpenAlex.
- A digital twin-enhanced decision support system improves time-in-range in type 1 diabetes: a randomized clinical trial.Scientific reports · 2025Trial
- Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study.Diabetes care · 2025Trial
- A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.Nature communications · 2025Trial
- Toward Personalized Decision Support Systems for Type 1 Diabetes: Integrating Psychobehavioral Factors and Glycemic Control.Journal of diabetes science and technology · 2025Trial
- Randomised Controlled Multicentre Trial to Investigate the Effectiveness of a Mobile Artificial Intelligence Solution for Diabetes Adapted Care: The MELISSA Trial Protocol.Diabetes, obesity & metabolism · 2026Article
- The Analytical Framework of Clinical Trials Evaluating Clinical Outcomes of Artificial Intelligence-Based Digital Health Interventions: A Systematic Literature Review.Journal of market access & health policy · 2026Review
- Effectiveness of the Stage 4 Smart Insulin Pen DIA:CONN P8 for Glycemic Control in a Real-World Setting.Diabetes & metabolism journal · 2026Article
- Insulin Real-Time Advisor-a Decision Support Application for Insulin Therapy Coupled With the Continuous Glucose Monitoring: Impact on Glycemic Control on People With Type 1 Diabetes.Journal of diabetes science and technology · 2024Article
- Design andJournal of diabetes science and technology · 2024Article
- Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- Digital Technology for Diabetes.The New England journal of medicine · 2023Review
- Quantifying insulin-mediated and noninsulin-mediated changes in glucose dynamics during resistance exercise in type 1 diabetes.American journal of physiology. Endocrinology and metabolism · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 2 institutions in 2 countries.
Jessica R CastleDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-1179-5374
Leah M WilsonDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-3634-481X
Nichole S TylerDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Alejandro Z EspinozaDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Clara M Mosquera-LopezDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-1586-2490
Taisa KushnerDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-2726-0465
Gavin M YoungDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Joseph PinsonaultDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Robert H DodierDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Wade W HiltsDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Sos M OganessianDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Deborah L BraniganDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.
Virginia B GaboDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.
Jae H EomDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.
Katrina RamseyBiostatistics & Design Program, Oregon Health & Science University, Portland, Oregon, USA.
Joseph El YoussefDepartment of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, Oregon, USA.
Joseph A CafazzoCentre for Global eHealth Innovation, Techna Institute, University Health Network, Toronto, Canada.
Kerri Winters-StoneDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Peter G JacobsDepartment of Biomedical Engineering, Artificial Intelligence for Medical Systems Lab, Oregon Health & Science University, Portland, Oregon, USA.
Oregon Health & Science University · USUniversity Health Network · CA
Funding
Improving glucose control with advanced technology designed for high risk patients with type 1 diabetesR01DK120367 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOBS, PETER G, WILSON, LEAH MEGAN · 2018 to 2021
$2.4MLeveraging Big Data and Deep Learning to Develop Next Generation Decision Support Tools to Improve Glycemic Outcomes in Type 1 DiabetesF30DK128914 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI YOUNG, GAVIN · 2021 to 2024
$209kNIDDK NIH HHS F30 DK128914NIDDK NIH HHS R01 DK120367
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1InsulinAdultBlood GlucoseBlood Glucose Self-MonitoringGlycated HemoglobinHumansHypoglycemic AgentsBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinContinuous glucose monitoringDecision supportExerciseHypoglycemiaType 1 diabetes
Identifiers
What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.